Figure 5.
Deterministic simulation of lung viral load profiles over time. Example simulations demonstrating that earlier drug administration is associated with greater reduction in viral load relative to placebo. Colored lines represent a simulated viral load profile for a typical patient infused with bamlanivimab (700 mg) on day 1, 3, or 10 and the black line represents simulated placebo.